Liver Disease


Clinical Investigation Site Summary: The Institute for Liver Health Treating Nonalcoholic Steatohepatitis (NASH)

As part of Trialsite News’ ongoing summary of clinical research sites across multiple facets of the clinical trial industry, we have included below a cursory review of The Institute for Liver Health, a clinical investigation site studying the treatment of Nonalcoholic...

The Emerging NASH Crisis

R&D Points Toward NASH In late 2018, Bay Area-based Gilead, known for HIV and Hepatitis C drugs, structured a deal worth up to $1.5 billion with Cambridge, MA-based Scholar Rock Holdings Corporation. Gilead would immediately pay $80 million in upfront payments...

Pin It on Pinterest